A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.
Condition(s):Urothelial Carcinoma; Renal Cell Carcinoma; MelanomaLast Updated:August 14, 2023Recruiting